Skip to main content
Fig. 1 | Pediatric Rheumatology

Fig. 1

From: A case report of a novel compound heterozygous mutation in a Brazilian patient with deficiency of Interleukin-1 receptor antagonist (DIRA)

Fig. 1

Clinical follow up. Femur x-ray before (a) and after treatment (b) with narrows indicating resolution of severe osteomyelitic lesions and (c) with an initial pustular rash in the forearms observed. The thoracic X-Ray (d) with black narrow indicating an acute osteomyelitis in the 7th rib during a flare induced by canakinumab. The figure (e) shows laboratory control of acute reactant markers before and after the treatment and the inflammation induced by the drug induced flare

Back to article page